Effect of single-dose crystalloid cardioplegic agent compared to bloody cardioplegic agent in cardiac surgery in children with Tetralogy of Fallot

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 117

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RYA-16-1_004

تاریخ نمایه سازی: 2 شهریور 1401

Abstract:

BACKGROUND: Cardioplegia is one of the main post-operative cardiac protective factors widely used in recent decades in the form of crystalloid (St. Thomas) and bloody solutions [del Nido (DN)]. The purpose of this study was to compare the effect of a crystalloid cardioplegic agent (St. Thomas) with that of a bloody cardioplegic agent (DN) in pediatric cardiac surgery among children with Tetralogy of Fallot (TOF).METHODS: This study was performed on ۶۰ children with TOF, who were candidates for heart repair surgery. The participants were randomly divided into two groups of crystalloid cardioplegic agent and bloody cardioplegic agent. Operative outcomes such as required time for onset of heart arrest, duration of returning to normal heart rhythm, and cardiopulmonary bypass (CPB) time, and operative complications were compared between the two groups.RESULTS: The duration of returning to normal heart rhythm (۵۰.۴۳ ± ۱۰.۹۳ seconds vs. ۴۳.۰۳ ± ۱۶.۳۵ seconds; P = ۰.۰۴۴) and duration of inotropy (۸۰.۴۰ ± ۲۷.۱۴ hours vs. ۶۳.۲۰ ± ۲۶.۹۱ hours; P = ۰.۰۱۷) were significantly higher in the DN group compared to the St. Thomas group. However, there were no significant differences between the two groups in terms of heart arrest time, cross-clamp time, CPB time, supplementary lasix‎ time, duration of intubation, and intensive care unit (ICU) and hospital length of stay (LOS) (P > ۰.۰۵۰).CONCLUSION: The use of St. Thomas cardioplegic solution was more effective in reducing the duration of returning to normal heart rhythm and inotropy compared with DN cardioplegic agent, and a single dose of these two cardioplegic agents can keep the mean cardiac arrest duration within the range of ۵۰-۷۰ minutes. It seems that the use of St. Thomas cardioplegic solution can be suggested in pediatric heart surgery. 

Authors

Hamid Bigdelian

Associate Professor, Department of Cardiac Surgery, School of Medicine AND Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Alireza Hosseini

Assistant Professor, Department of Cardiac Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Kotani Y, Tweddell J, Gruber P, Pizarro C, Austin EH ...
  • Cooley DA, Reul GJ, Wukasch DC. Ischemic contracture of the ...
  • Yamamoto H, Yamamoto F. Myocardial protection in cardiac surgery: A ...
  • Kouchoukos NT, Blackstone EH, Hanley FL, Kirklin JK. Kirklin/Barratt-Boyes Cardiac ...
  • Feindel CM, Tait GA, Wilson GJ, Klement P, MacGregor DC. ...
  • Fallouh HB, Kentish JC, Chambers DJ. Targeting for cardioplegia: Arresting ...
  • Buckberg GD. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: Operative ...
  • Jonas RA. Myocardial protection. In: Jonas R, Editor. Comprehensive Surgical ...
  • Buel ST, Striker CW, O'Brien JE. del Nido versus St. ...
  • Liu J, Feng Z, Zhao J, Li B, Long C. ...
  • Charette K, Gerrah R, Quaegebeur J, Chen J, Riley D, ...
  • Mimic B, Ilic S, Vulicevic I, Milovanovic V, Tomic D, ...
  • Fazelifar S, Bigdelian H. Effect of esmolol on myocardial protection ...
  • Kim K, Ball C, Grady P, Mick S. Use of ...
  • Mishra P, Jadhav RB, Mohapatra CK, Khandekar J, Raut C, ...
  • Gorjipour F, Dehaki MG, Totonchi Z, Hajimiresmaiel SJ, Azarfarin R, ...
  • Matte GS, del Nido PJ. History and use of del ...
  • Sorabella RA, Akashi H, Yerebakan H, Najjar M, Mannan A, ...
  • O'Brien JD, Howlett SE, Burton HJ, O'Blenes SB, Litz DS, ...
  • Talwar S, Bhoje A, Sreenivas V, Makhija N, Aarav S, ...
  • Suleiman MS, Hancock M, Shukla R, Rajakaruna C, Angelini GD. ...
  • Valooran GJ, Nair SK, Chandrasekharan K, Simon R, Dominic C. ...
  • Tsukube T, McCully JD, Federman M, Krukenkamp IB, Levitsky S. ...
  • O'Blenes SB, Friesen CH, Ali A, Howlett S. Protecting the ...
  • Kim JS, Jeong JH, Moon SJ, Ahn H, Hwang HY. ...
  • Pourmoghadam KK, Ruzmetov M, O'Brien MC, Piggott KD, Plancher G, ...
  • Ramanathan R, Parrish DW, Armour TK, Brinster DR. Use of ...
  • Smigla G, Jaquiss R, Walczak R, Bonadonna D, Kaemmer D, ...
  • Mick SL, Robich MP, Houghtaling PL, Gillinov AM, Soltesz EG, ...
  • Ota T, Yerebakan H, Neely RC, Mongero L, George I, ...
  • Yerebakan H, Sorabella RA, Najjar M, Castillero E, Mongero L, ...
  • نمایش کامل مراجع